Lantern Pharma (LTRN) Operating Leases (2021 - 2026)
Lantern Pharma's (LTRN) quarterly Operating Leases came in at $59076.0 in Q1 2026, little changed YoY from $59076.0 in Q1 2025, and down 24.78% on a QoQ basis from $78539.0 in Q4 2025.
Lantern Pharma (LTRN) Operating Leases (2021 - 2026) Analysis & Trends
Lantern Pharma (LTRN) has 6 years of Operating Leases data on file, last reported at $59076.0 in Q1 2026.
- Quarterly Operating Leases changed 0.0% year-over-year to $59076.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59076.0 (changed 0.0% YoY) and the FY2025 annual result came in at $78539.0, up 48.63% from the prior year.
- Operating Leases slipped to $59076.0 in Q1 2026, from $78539.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $291244.0 in Q3 2024 to a low of $13299.0 in Q1 2022.
- A 5-year average of $96928.4 and a median of $70017.5 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases jumped 957.46% — and 2025, when it tumbled 75.27%.
- Tracing LTRN's Operating Leases over 5 years: stood at $52890.0 in 2022, then grew by 16.27% to $61496.0 in 2023, then declined by 14.07% to $52843.0 in 2024, then jumped by 48.63% to $78539.0 in 2025, then slipped by 24.78% to $59076.0 in 2026.
- The last three Operating Leases figures came in at $59076.0 (Q1 2026), $78539.0 (Q4 2025), and $13524.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Lantern Pharma | 26.11 Mn | 26.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,076.00 |
| Dec 31, 2025 | 78,539.00 |
| Jun 30, 2025 | 13,524.00 |
| Mar 31, 2025 | 59,076.00 |
| Dec 31, 2024 | 52,843.00 |
| Sep 30, 2024 | 291,244.00 |
| Jun 30, 2024 | 54,694.00 |
| Mar 31, 2024 | 193,584.00 |
| Dec 31, 2023 | 61,496.00 |
| Sep 30, 2023 | 106,516.00 |
| Jun 30, 2023 | 150,713.00 |
| Mar 31, 2023 | 140,632.00 |
| Dec 31, 2022 | 52,890.00 |
| Sep 30, 2022 | 92,023.00 |
| Jun 30, 2022 | 130,705.00 |
| Mar 31, 2022 | 13,299.00 |
| Dec 31, 2021 | 204,948.00 |
| Sep 30, 2021 | 240,984.00 |
| Jun 30, 2021 | 130,705.00 |